ProAxsis are delighted to announce that the company will be presenting results from several recent projects at the European Respiratory Society …
Type and hit ENTER
News
September 3, 2021
York and Belfast, UK (August 19th, 2021) – Aptamer Group, the developer of custom affinity ligands to enable the life science …
August 19, 2021
As part of its ongoing expansion plans, ProAxsis Limited, the Belfast-based diagnostics company, is pleased to announce two new appointments within …
June 21, 2021
ProAxsis Limited (www.proaxsis.com), the Belfast-based respiratory diagnostics company, is delighted to announce it has entered into an exclusive licensing agreement with …
June 7, 2021
Introduction In parallel with the release of the company’s 2020 financial statements, I am pleased to provide an associated update on …
May 21, 2021
ProAxsis (www.proaxsis.com), the Belfast-based diagnostics company, and a collaboration of the University of Geneva and the University Hospital of Geneva, today …
February 21, 2021
ProAxsis Limited (www.proaxsis.com), the Belfast-based diagnostics company specialising in the measurement of active proteases and other inflammatory biomarkers, today announces that …
December 14, 2020
ProAxsis (www.proaxsis.com), the Belfast-based respiratory diagnostics company, today announces that it has been awarded a high impact Innovate UK grant as …
December 10, 2020
ProAxsis (www.proaxsis.com), the Belfast-based protease diagnostics company, is delighted to announce that it has been recognised as a Gold Level Innovator …
December 2, 2020
ProAxsis Limited (www.proaxsis.com), the Belfast-based diagnostics company specialising in the measurement of active proteases and other inflammatory biomarkers, today announces that …
November 19, 2020
ProAxsis Ltd
Unit 1B, Concourse Building 3,
Catalyst Inc,
Queen’s Road, Titanic Quarter,
Belfast,
BT3 9DT,
Northern Ireland
tel +44 (0)28 9073 0444
email info@proaxsis.com
Copyright © 2016-2021 - ProAxsis - All rights reserved.
News Archives - Page 2 of 7 - ProAxsis